Skip to content

Clinical trials

Phase 1 Lymphoma, Non-Hodgkin trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Non-Hodgkin Phase: Phase 1 Country / region: Japan Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20082
20101
20112
20131
20141
20151
20162
20175
20181
20191
20201
20211
20224
20231
20243
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated10
Active, not recruiting7
Recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Janssen Research & Development, LLC4
Celgene3
Eli Lilly and Company3
AbbVie2
Pfizer2
SymBio Pharmaceuticals2
Amgen1
Bayer1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Non-Hodgkin31
Lymphoma, Large B-Cell, Diffuse9
Lymphoma, Follicular7
Neoplasms7
Leukemia, Myeloid, Acute6
Leukemia, Lymphocytic, Chronic, B-Cell5
Lymphoma, B-Cell5
Lymphoma, Mantle-Cell5
Multiple Myeloma5
Lymphoma4

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.